Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Retatrutide is not currently available as a licensed treatment in the UK and may only be accessed through approved clinical trial settings
Any early weight changes may be attributed to: Reduced caloric intake due to appetite suppression Decreased fluid retention in some individuals Changes in glycogen stores and associated water weight Reduced food volume in the digestive system It is important to understand that week one weight changes are not indicative of long-term results
You Don't Have to Wait for Retatrutide to Protect Muscle While retatrutide's body composition data is promising, the reality is that you can address muscle preservation right now by combining current GLP-1 medications with hormone optimization and peptide therapy
The sublingual route may be simpler to prepare and administer than nasal spray but has its own challenges, including peptide degradation by salivary enzymes and the difficulty of keeping the solution under the tongue long enough for absorption
Tirzepatide (Mounjaro, Zepbound) is actually a dual GIP/GLP-1 receptor agonist
